- Home
- ACHV vs MNTK Comparison
ACHV vs MNTK Comparison
Compare ACHV & MNTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ACHV | MNTK |
|---|---|---|
| Founded | N/A | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Natural Gas Distribution |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.2M | 194.2M |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ACHV | MNTK |
|---|---|---|
| Price | $2.89 | $1.25 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 3 |
| Target Price | ★ $15.50 | $3.33 |
| AVG Volume (30 Days) | ★ 615.8K | 297.4K |
| Earning Date | 03-24-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | N/A | ★ $176,382,000.00 |
| Revenue This Year | N/A | $21.75 |
| Revenue Next Year | $578.60 | $17.64 |
| P/E Ratio | ★ N/A | $112.00 |
| Revenue Growth | N/A | ★ 0.37 |
| 52 Week Low | $1.84 | $1.07 |
| 52 Week High | $6.03 | $2.78 |
Technical Indicators
Market Signals| Indicator | ACHV | MNTK |
|---|---|---|
| Relative Strength Index (RSI) | 24.33 | 39.19 |
| Support Level | $2.38 | N/A |
| Resistance Level | $3.39 | $2.07 |
| Average True Range (ATR) | 0.25 | 0.13 |
| MACD | -0.15 | -0.02 |
| Stochastic Oscillator | 11.27 | 32.26 |
Price Performance
Historical ComparisonAbout ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About MNTK Montauk Renewables Inc.
Montauk Renewables Inc is a renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments namely Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.